The Impact of Pdcd4, a Translation Inhibitor, on Drug Resistance

被引：0
|
作者：
Wang, Qing [1 ]
Yang, Hsin-Sheng [1 ,2 ]
机构：
[1] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA
[2] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA
来源：
PHARMACEUTICALS | 2024年 / 17卷 / 10期
关键词：
eIF4A; mTORC2-Akt pathway; beta-catenin pathway; JNK pathway; paclitaxel; doxorubicin; fluorouracil; platinum-containing drug; IGF1R/IR inhibitor; SUPPRESSOR PROTEIN PDCD4; NF-KAPPA-B; TRANSFORMATION SUPPRESSOR; CANCER CELLS; DEPENDENT TRANSCRIPTION; EUKARYOTIC TRANSLATION; DOXORUBICIN RESISTANCE; MOLECULAR-MECHANISMS; ARGININE METHYLATION; MAMMALIAN TARGET;
D O I：
10.3390/ph17101396
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Programmed cell death 4 (Pdcd4) is a tumor suppressor, which has been demonstrated to efficiently suppress tumorigenesis. Biochemically, Pdcd4 binds with translation initiation factor 4A and represses protein translation. Beyond its role in tumor suppression, growing evidence suggests that Pdcd4 enhances the chemosensitivity of several anticancer drugs. To date, numerous translational targets of Pdcd4 have been identified. These targets govern important signal transduction pathways, and their attenuation may improve chemosensitivity or overcome drug resistance. This review will discuss the signal transduction pathways regulated by Pdcd4 and the potential mechanisms through which Pdcd4 enhances chemosensitivity or counteracts drug resistance.
引用
收藏
页数：12
相关论文
共 50 条
  • [21] A novel mechanism for the control of translation of specific mRNAs by tumor suppressor protein Pdcd4: inhibition of translation elongation
    A Biyanee
    J Ohnheiser
    P Singh
    K-H Klempnauer
    Oncogene, 2015, 34 : 1384 - 1392
  • [22] A novel mechanism for the control of translation of specific mRNAs by tumor suppressor protein Pdcd4: inhibition of translation elongation
    Biyanee, A.
    Ohnheiser, J.
    Singh, P.
    Klempnauer, K-H
    ONCOGENE, 2015, 34 (11) : 1384 - 1392
  • [23] Dissecting the Roles of PDCD4 in Breast Cancer
    Cai, Qian
    Yang, Hsin-Sheng
    Li, Yi-Chen
    Zhu, Jiang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [24] Function and modulation of Pdcd4 in ovarian cancer
    Liu, Stephanie S.
    Wei, Tina N.
    Chan, Karen K. L.
    Ngan, Hextan Y. S.
    CANCER RESEARCH, 2011, 71
  • [25] miR-182 contributes to cell adhesion-mediated drug resistance in multiple myeloma via targeting PDCD4
    Wu, Yaxun
    Zhu, Xinghua
    Shen, Rong
    Huang, Jieyu
    Xu, Xiaohong
    He, Song
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (11)
  • [26] Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma
    Wang, Qing
    Zhu, Jiang
    Yang, Hsin-Sheng
    CANCER RESEARCH, 2017, 77
  • [27] RNA-binding proteins La and HuR cooperatively modulate translation repression of PDCD4 mRNA
    Kumar, Ravi
    Poria, Dipak Kumar
    Ray, Partho Sarothi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296
  • [28] Pdcd4 directly binds the coding region of c-myb mRNA and suppresses its translation
    Singh, P.
    Wedeken, L.
    Waters, L. C.
    Carr, M. D.
    Klempnauer, K-H
    ONCOGENE, 2011, 30 (49) : 4864 - 4873
  • [29] Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma
    Wang, Q.
    Zhu, J.
    Wang, Y-W
    Dai, Y.
    Wang, Y-L
    Wang, C.
    Liu, J.
    Baker, A.
    Colburn, N. H.
    Yang, H-S
    ONCOGENE, 2017, 36 (45) : 6225 - 6234
  • [30] Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma
    Q Wang
    J Zhu
    Y-W Wang
    Y Dai
    Y-L Wang
    C Wang
    J Liu
    A Baker
    N H Colburn
    H-S Yang
    Oncogene, 2017, 36 : 6225 - 6234
12345